We use cookies to provide you with the best of services and customized features. By continuing to browse this website, you give your informed consent to our Cookie Policy.
The University of Nizwa has registered a new patent for using nanotechnology to initiate change to Budesonide, the medicine used to treat inflammatory bowel disease (IBD).
